Prevalence and Medications of Atopic Dermatitis in Germany: Claims Data Analysis

References

• Langenbruch A, Radtke M, Franzke N, Ring J, Foelster-Holst R, Augustin M. Quality of health care of atopic eczema in Germany: results of the National Health Care Study AtopicHealth. J Eur Acad Dermatol Venereol. 2014;28(6):719–726. doi:10.1111/jdv.1215423560545
   PubMed Web of Science ®Google Scholar
• Misery L, Finlay AY, Martin N, et al. Atopic dermatitis: impact on the quality of life of patients and their partners. Dermatology. 2007;215(2):123–129. doi:10.1159/00010426317684374
   PubMed Web of Science ®Google Scholar
• Gutknecht M, Reinert R, Augustin M. Review of health economic analyses in atopic dermatitis: how diverse is the literature? Expert Rev Pharmacoecon Outcomes Res. 2019;19(2):127–145. doi:10.1080/14737167.2019.154949130590976
   PubMed Web of Science ®Google Scholar
• Nørreslet LB, Ebbehøj NE, Ellekilde Bonde JP, Thomsen SF, Agner T. The impact of atopic dermatitis on work life - a systematic review. J Eur Acad Dermatol Venereol. 2018;32(1):23–38. doi:10.1111/jdv.1452328833648
   PubMed Web of Science ®Google Scholar
• Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483–1494. doi:10.1056/NEJMra07408118385500
   PubMed Web of Science ®Google Scholar
• Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35(3):283–289. doi:10.1016/j.det.2017.02.00228577797
   PubMed Web of Science ®Google Scholar
• Carroll CL, Balkrishnan S, Feldman SR, Fleischer AB, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005;22:192–199. doi:10.1111/j.1525-1470.2005.22303.x15916563
   PubMed Web of Science ®Google Scholar
• Lewis V, Finlay A. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004;9::169−169. doi:10.1111/j.1087-0024.2004.09113.x
   PubMed Web of Science ®Google Scholar
• Schäfer I, Rustenbach SJ, Zimmer L, Augustin M. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology. 2008;217:169–172. doi:10.1159/00013665618525204
   PubMed Web of Science ®Google Scholar
• Schmitt J. Behandlungsziele und Zufriedenheit mit der medizinischen Versorgung von Erwachsenen mit Neurodermitis. In: Kirch W, Badura B, Pfaff H, editors. Prävention Und Versorgungsforschung. Berlin: Springer; 2008:819–832.
   Google Scholar
• Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schäfer I. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol. 2011;165(4):865–873. doi:10.1111/j.1365-2133.2011.10436.x21623753
   PubMed Web of Science ®Google Scholar
• Langen U, Schmitz R, Steppuhn H. Prevalence of allergic diseases in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5−6):698–706.23703488
   PubMed Web of Science ®Google Scholar
• Augustin M, Radtke MA, Glaeske G, et al. Epidemiology and comorbidity in children with psoriasis and atopic eczema. Dermatology. 2015;231:35–31. doi:10.1159/00038191325966818
   PubMed Web of Science ®Google Scholar
• Radtke MA, Schäfer I, Glaeske G, Jacobi A, Augustin M. Prevalence and comorbidities in adults with psoriasis compared to atopic eczema. J Eur Acad Dermatol Venereol. 2017;31(1):151–157. doi:10.1111/jdv.1381327521212
   PubMed Web of Science ®Google Scholar
• Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284–1293. doi:10.1111/all.1340129319189
   PubMed Web of Science ®Google Scholar
• Thamm R, Poethko-Müller C, Hüther A, Thamm M. Allergische Erkrankungen bei Kindern und Jugendlichen in Deutschland – querschnittergebnisse aus KiGGS Welle 2 und Trends. J Health Monit. 2018;3(3):3–18.
   Google Scholar
• Zander N, Augustin M, Reinert R, Schäfer I. Atopic dermatitis shows significant cutaneous comorbidity: results from large-scale investigations in the working population. J Eur Acad Dermatol Venereol. 2020;34(1):135–141. doi:10.1111/jdv.1579231301682
   PubMed Web of Science ®Google Scholar
• Ha J, Lee SW, Yon DK. Ten-Year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008–2017. Clin Exp Pediatr. 2020;63(7):278–283. doi:10.3345/cep.2019.0129132023407
   PubMedGoogle Scholar
• Steinke S, Langenbruch A, Ständer S, Franzke N, Augustin M. Therapeutic benefits in atopic dermatitis care from the patients’ perspective. Results of the German National Health Care Study ‘Atopic Health’. Dermatology. 2014;1(4):358–364.
   Google Scholar
• Statutory health insurance [homepage on the Internet]. Bonn: GKV-Spitzenverband; 2019. Available from: https://www.gkv-spitzenverband.de/english/statutory_health_insurance/statutory_health_insurance.jsp. Accessed 53, 2020.
   Google Scholar
• Busse R, Blumel M. Germany: health system review. Health Syst Transit. 2014;16(2):1–296.
   PubMedGoogle Scholar
• Niedner R. Glukokortikosteroide in der Dermatologie: kontrollierter Einsatz erforderlich. Dt Ärztebl. 1996;93:A–2868–72.
   Google Scholar
• Hoffmann W, Latza U, Baumeister SE, et al. Guidelines and recommendations for ensuring Good Epidemiological Practice (GEP): a guideline developed by the German Society for Epidemiology. Eur J Epidemiol. 2019;34(3):301–317. doi:10.1007/s10654-019-00500-x30830562
   PubMed Web of Science ®Google Scholar
• Swart E, Ihle P, Gothe H, Matusiewicz D. editors. Routinedaten im Gesundheitswesen - Handbuch Sekundärdatenanalyse: Grundlagen, Methoden und Perspektiven. 2nd ed. Bern: Verlag Hans Huber; 2014.
   Google Scholar
• KM 6-Statistik (gesetzliche Krankenversicherung: Versicherte). [homepage on the Internet]. Ort: gesundheitsberichterstattung des Bundes (BGE-Bund); 2020. Available from: http://www.gbe-bund.de/gbe10/trecherche.prc_them_rech?tk=2700&tk2=2730&p_uid=gast&p_aid=0&p_sprache=D&cnt_ut=0&ut=2730. Accessed 94, 2020.
   Google Scholar
• Heratizadeh A, Haufe E, Stölzl D, et al. Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany. J Eur Acad Dermatol Venereol. 2020;34(6):1263–1272. doi:10.1111/jdv.1607831721316
   PubMed Web of Science ®Google Scholar
• Alexander H, Paller AS, Traidl-Hoffmann C, et al. The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group. Br J Dermatol. 2020;182(6):1331–1342. doi:10.1111/bjd.1864331677162
   PubMed Web of Science ®Google Scholar
• Darsow U, Pfab F, Valet M, et al. Pruritus and atopic dermatitis. Clin Rev Allergy Immunol. 2011;41(3):237–244. doi:10.1007/s12016-010-8230-221207193
   PubMed Web of Science ®Google Scholar
• Mohan GC, Silverberg JI. Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis. JAMA Dermatol. 2015;151(5):522–528. doi:10.1001/jamadermatol.2014.332425471826
   PubMed Web of Science ®Google Scholar
• Werfel T, Heratizadeh A, Aberer W, et al. S2k guideline on diagnosis and treatment of atopic dermatitis - short version. J Dtsch Dermatol Ges. 2016;14(1):92–106. doi:10.1111/ddg.1287126713654
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. doi:10.1111/jdv.1489129676534
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32(6):850–878.29878606
   PubMed Web of Science ®Google Scholar
• Garside R, Stein K. Castelnuovo et al. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. Health Technol Assess. 2005;9(29):1–230. doi:10.3310/hta9290
   Web of Science ®Google Scholar
• Fröschl B, Arts D, Leopold C. Topische antientzündliche Behandlung der Neurodermitis im Kindesalter. GMS Health Technol Assess. 2007;3:Doc09.21289943
   PubMedGoogle Scholar
• Roekevisch E, Spuls PI, Kuester D, Limpens J, Schmitt J. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol. 2014;133(2):429–438. doi:10.1016/j.jaci.2013.07.04924269258
   PubMed Web of Science ®Google Scholar
• Schmitt J, Schaekel K, Foelster-Holst R, et al. Prednisolone vs. ciclosporin for severe adult eczema - an investigator-initiated double-blind placebo-controlled multicentre trial. Br J Dermatol. 2010;162(3):661–668. doi:10.1111/j.1365-2133.2009.09561.x19863501
   PubMed Web of Science ®Google Scholar
• Seegräber M, Srour J, Walter A, Knop M, Wollenberg A. Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol. 2018;11(5):467–474. doi:10.1080/17512433.2018.144964229557246
   PubMed Web of Science ®Google Scholar
• Werfel T, Heratizadeh A, Aberer W et al. Aktualisierung „Systemtherapie bei Neurodermitis“ zur Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] Entwicklungsstufe: s2k; 2020. Available from: https://www.awmf.org/fileadmin/user_upload/Leitlinien/013_D_Dermatologische_Ges/013-027l_S2k_Neurodermitis_Aktualisierung-Systemtherapie_2020-06.pdf. Accessed 94, 2020.
   Google Scholar
• Schmitt J, Abraham S, Trautmann F, et al. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: first results of the German Atopic Eczema Registry TREATgermany. J Dtsch Dermatol Ges. 2017;15(1):49–59.
   Web of Science ®Google Scholar
• Schubert I, Ihle P, Köster I. Verwendung von GKV-Diagnosen in der Sekundärdatenfoschung. In: Swart E, Ihle P, editors. Routinedaten Im Gesundheitswesen – Handbuch Sekundärdatenanalyse: Grundlagen, Methoden Und Perspektiven. Bern: Verlag Hans Huber; 2005:235–242.
   Google Scholar
• Hoffmann F, Icks A. Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor. Gesundheitswesen. 2012;74(5):291–297.21755492
   PubMed Web of Science ®Google Scholar